Regulation of Vascular Reactivity in Scleroderma: New Insights into Raynaud's Phenomenon

Rheumatic Disease Clinics of North America

Volumn 34, Issue 1, 2008, Pages 81-87

  Flavahan, Nicholas A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; DRUG MECHANISM; ENZYME ANALYSIS; FIBROSIS; HEAT SENSITIVITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAYNAUD PHENOMENON; REGULATORY MECHANISM; REVIEW; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN BLOOD VESSEL; STRESS; VASOCONSTRICTION; VASODILATATION;

COLD; HUMANS; MUSCLE, SMOOTH, VASCULAR; RAYNAUD DISEASE; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC; RHO-ASSOCIATED KINASES; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN TEMPERATURE;

EID: 40149105688     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.12.005     Document Type: Review

References (41)

1. Vanhoutte P.M. Physical factors of regulation. In: Bohr D.F., Somlyo A.P., and Sparks H.V. (Eds). Handbook of physiology (1980), American Physiological Society, Washington (DC) 443-474
2. Flavahan N.A., Cooke J.P., Shepherd J.T., et al. Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J Pharmacol Exp Ther 241 (1987) 361-365
3. Hein L., Altman J.D., and Kobilka B.K. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402 (1999) 181-184
4. Flavahan N.A., Rimele T.J., Cooke J.P., et al. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther 230 (1984) 699-705
5. Flavahan N.A., and McGrath J.C. Are human vascular alpha-adrenoceptors atypical ?. [letter]. J Cardiovasc Pharmacol 6 (1984) 208-210
6. Flavahan N.A., Lindblad L.E., Verbeuren T.J., et al. Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am J Physiol 249 (1985) H950-H955
7. Flavahan N.A., and Vanhoutte P.M. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins. J Pharmacol Exp Ther 238 (1986) 139-147
8. Chotani M.A., Flavahan S., Mitra S., et al. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol Heart Circ Physiol 278 (2000) H1075-H1083
9. Flavahan N.A., and Vanhoutte P.M. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. J Pharmacol Exp Ther 238 (1986) 131-138
10. Chotani M.A., Mitra S., Su B.Y., et al. Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286 (2004) H59-H67
11. Lindblad L.E., and Ekenvall L. Alpha 2-adrenoceptor inhibition in patients with vibration white fingers. Kurume Med J 37 Suppl (1990) S95-S99
12. Freedman R.R., Baer R.P., and Mayes M.D. Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 92 (1995) 1448-1451
13. Block J.A., and Sequeira W. Raynaud's phenomenon. Lancet 357 (2001) 2042-2048
14. Jeyaraj S.C., Chotani M.A., Mitra S., et al. Cooling evokes redistribution of α2C-adrenoceptors from Golgi to plasma membrane in transfected HEK293 cells. Mol Pharmacol 60 (2001) 1195-1200
15. MacDonald E., Kobilka B.K., and Scheinin M. Gene targeting: homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18 (1997) 211-219
16. Philipp M., Brede M., and Hein L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. Am J Physiol Regul Integr Comp Physiol 283 (2002) R287-R295
17. Daunt D.A., Hurt C., Hein L., et al. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol 51 (1997) 711-720
18. Hurt C.M., Feng F.Y., and Kobilka B. Cell-type specific targeting of the alpha 2c-adrenoceptor: evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J Biol Chem 275 (2000) 35424-35431
19. Bailey S.R., Eid A.H., Mitra S., et al. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res 94 (2004) 1367-1374
20. Bailey S.R., Mitra S., Flavahan S., et al. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289 1 (2005) H243-H250
21. Kajimoto H., Hashimoto K., Bonnet S.N., et al. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115 (2007) 1777-1788
22. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
23. Fukata Y., Amano M., and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22 (2001) 32-39
24. Somlyo A.P., and Somlyo A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 (2003) 1325-1358
25. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4 (2003) 446-456
26. Honda M., Suzuki M., Nakayama K., et al. Role of alpha2C-adrenoceptors in the reduction of skin blood flow induced by local cooling in mice. Br J Pharmacol 152 (2007) 91-100
27. Thompson-Torgerson C.S., Holowatz L.A., Flavahan N.A., et al. Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin. Am J Physiol Heart Circ Physiol 293 (2007) H30-H36
28. Thompson-Torgerson C.S., Holowatz L.A., Flavahan N.A., et al. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol 292 (2007) H1700-H1705
29. Hodges G.J., Zhao K., Kosiba W.A., et al. The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans. J Physiol 574 (2006) 849-857
30. Liao J.K., Seto M., and Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50 (2007) 17-24
31. Rikitake Y., and Liao J.K. Rho GTPases, statins, and nitric oxide. Circ Res 97 (2005) 1232-1235
32. Xi Q., Cheranov S.Y., and Jaggar J.H. Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2+ sparks. Circ Res 97 (2005) 354-362
33. Chotani M.A., Mitra S., Eid A.H., et al. Distinct cyclic AMP signaling pathways differentially regulate α2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am J Physiol Heart Circ Physiol 288 (2005) H69-H76 [Epub 2004 Sep 2]
34. Eason M.G., and Liggett S.B. Subtype-selective desensitization of alpha 2-adrenergic receptors: different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. J Biol Chem 267 (1992) 25473-25479
35. Jewell-Motz E.A., and Liggett S.B. G protein-coupled receptor kinase specificity for phosphorylation and desensitization of alpha2-adrenergic receptor subtypes. J Biol Chem 271 (1996) 18082-18087
36. Jewell-Motz E.A., Donnelly E.T., Eason M.G., et al. Role of the amino terminus of the third intracellular loop in agonist-promoted downregulation of the alpha2A-adrenergic receptor. Biochemistry 36 (1997) 8858-8863
37. Eid A.H., Maiti K., Mitra S., et al. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 293 (2007) H1955-H1961
38. Kuwana M. Potential benefit of statins for vascular disease in systemic sclerosis. Curr Opin Rheumatol 18 (2006) 594-600
39. Derk C.T., and Jimenez S.A. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?. Autoimmun Rev 5 (2006) 25-32
40. Furukawa S., Yasuda S., Amengual O., et al. Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. Ann Rheum Dis 65 (2006) 1118-1120
41. Kuwana M., Kaburaki J., Okazaki Y., et al. Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum 54 (2006) 1946-1951